Results 201 to 210 of about 5,215,493 (360)

Delivery technologies for cancer immunotherapy

Nature reviews. Drug discovery, 2019
Rachel S. Riley, C. June, R. Langer, M. J. Mitchell   +3 more
semanticscholar   +1 more source

Gemcitabine in the Era of Cancer Immunotherapy

, 2020
Katarzyna Piadel, Angus Dalgleish, Peter L. Smith   +2 more
openalex   +1 more source

P1.04-22 Potential DNA Repair Biomarker for Response to Immunotherapy of Lung Cancer Patients [PDF]

, 2019
Zvi Livneh, Tamar Paz-Elizur, Yael Leitner‐Dagan, Kerstin B. Meyer, Barak Markus, Federico M. Giorgi, Martin O’Reilly, H. Kim, Yentl Evgy, Robert C. Rintoul, B. Ponder   +10 more
openalex   +1 more source

Engineering a Sonotherapeutic RBC Membrane‐Derived Nanoparticle Platform for the Treatment of Liver Cancer

Advanced Functional Materials, EarlyView.
Herein, an RBC membrane‐derived nanoparticle (CMN‐ICG) is engineered to efficiently deliver a sonosensitizing agent, indocyanine green (ICG), for sonotherapy of hepatocellular carcinoma (HCC). CMN‐ICG exhibits excellent cytocompatibility, significantly enhances hepatocyte uptake, and produces excessive reactive oxygen species (ROS) upon ultrasound ...
Alap Ali Zahid, Aishik Chakraborty, Wei Luo, Juhi Bora, John Joseph Kelly, John Andrew Ronald, Arghya Paul   +6 more
wiley   +1 more source

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Journal for ImmunoTherapy of Cancer, 2017
Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis   +11 more
doaj   +1 more source

Cancer immunotherapy comes of age

Nature, 2011
I. Mellman, G. Coukos, G. Dranoff
semanticscholar   +1 more source

Is dual immunotherapy needed in first-line treatment of microsatellite instability (MSI)-high metastatic colorectal cancer? [PDF]

, 2023
Sukeshi Patel Arora, Saranya Dinesan, Naga Cheedella, Shruti Pandita   +3 more
openalex   +1 more source

PRELIVE: A Framework for Predicting Lipid Nanoparticles In Vivo Efficacy and Reducing Reliance on Animal Testing

Advanced Functional Materials, EarlyView.
PREdicting LNP In Vivo Efficacy (PRELIVE) framework enables the prediction of lipid nanoparticle (LNPs) organ‐specific delivery through dual modeling approaches. Composition‐based models using formulation parameters and protein corona‐based models using biological fingerprints both achieve high predictive accuracy across multiple organs.
Belal I. Hanafy, Chuan‐En Lu, Kai Liu, Audrey Gallud   +3 more
wiley   +1 more source

Combinatorial approaches for cancer immunotherapy. [PDF]

Cancer Immunol Immunother
Spada S, Oweida A.
europepmc   +1 more source

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature, 2023
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A. Kessler, Clara H. Wolfe, Anne Jenney, Caitlin E. Mills, Emily J. Robitschek, Thomas G. R. Davis, Sarah Y. Kim, Amina Fu, Xiang Ma, Jia Gwee, P. Tiwari, Peter P. Du, P. Sindurakar, Jun Tian, Arnav Mehta, Alexis M. Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas J. LaSalle, T. Sharova, Hongyan Xie, Shuming Liu, W. Michaud, Rodrigo Saad-Beretta, Kathleen B. Yates, Arvin Iracheta-Vellve, J. Spetz, Xing-Lei Qin, K. Sarosiek, Gao Zhang, Jong Wook Kim, M. Su, Angelina M Cicerchia, Martin Q. Rasmussen, S. Klempner, D. Juric, S. Pai, D. Miller, A. Giobbie-Hurder, Jonathan H. Chen, K. Pelka, Dennie T. Frederick, Susanna Stinson, E. Ivanova, A. Aref, C. Paweletz, D. Barbie, Debattama R. Sen, D. Fisher, R. Corcoran, N. Hacohen, P. Sorger, K. Flaherty, G. Boland, R. Manguso, R. Jenkins   +58 more
semanticscholar   +1 more source